Insider · CIK 0001867575
Mohanjit Jolly
Files at HIND (ReShape Lifesciences Inc.). First filing -, latest -.
In brief
Mohanjit Jolly files SEC Form 4 as director at HIND (ReShape Lifesciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mohanjit Jolly has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | HIND ReShape Lifesciences Inc. | AGrant or award Stock Option (right to buy)derivative | +120,000 | $0.00 | $0 | 137,833 | 40 d ago |
| Aug 15, 2025 | HIND ReShape Lifesciences Inc. | AGrant or award Common Stockindirect: See footnote | +454,456 | - | - | 454,456 | Nov 18, 2025 |
Questions about Mohanjit Jolly
Answered from the filings on this page, as of the latest one.
Is Mohanjit Jolly buying or selling?
Mohanjit Jolly has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mohanjit Jolly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mohanjit Jolly has 0.
Where does Mohanjit Jolly file Form 4?
Mohanjit Jolly has filed Form 4 at HIND (ReShape Lifesciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.